2015
DOI: 10.1590/0100-69912015005007
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Roux-en-Y gastric bypass on lipid and inflammatory profiles

Abstract: Roux-en-Y gastric bypass promoted a decrease in plasma concentrations of CRP and Alpha-1-acid glycoprotein, improving lipid and inflammatory profiles.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
1
0
2

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 26 publications
1
1
0
2
Order By: Relevance
“…Both RYGB and LSG induced a drastic weight loss during the follow-up period, concomitantly with an improvement of glycemic parameters and insulin resistance, a decrease of triglyceride and an increase of HDL-cholesterol. A reduction of total and LDL-cholesterol was observed in the RYGB group but not in the LSG group, which is in agreement with previous studies [33,34]. As glycemic parameters including glycemia, insulinemia and C-peptide decreased post-operatively and glicentin progressively increased, it is not surprising that ratios of glicentin reported to glycemic parameters increased over time.…”
Section: Discussionsupporting
confidence: 92%
“…Both RYGB and LSG induced a drastic weight loss during the follow-up period, concomitantly with an improvement of glycemic parameters and insulin resistance, a decrease of triglyceride and an increase of HDL-cholesterol. A reduction of total and LDL-cholesterol was observed in the RYGB group but not in the LSG group, which is in agreement with previous studies [33,34]. As glycemic parameters including glycemia, insulinemia and C-peptide decreased post-operatively and glicentin progressively increased, it is not surprising that ratios of glicentin reported to glycemic parameters increased over time.…”
Section: Discussionsupporting
confidence: 92%
“…In several studies, the influence of MDA on LDL-C was also observed in different morbidities [19][20][21][22]. The total antioxidant capacity (TAC), homocysteinemia, C-reactive protein (CRP), alpha-1-acid glycoprotein (AGP), waist circumference (WC) and cholesterol intake, based on methodological protocols for different morbidities, LDL-C levels were correlated with these variables [11,[23][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%
“…Dentre as funções das proteínas encontradas, destacam-se: proteínas relacionadas ao metabolismo lipídico e glicídico (ASLEH et al, 2006;DABROWSKA et al, 2015;IX et al, 2006;JENSEN et al, 2014;KOHAN et al, 2015;LEE et al, 2010;MANSUY-AUBERT et al, 2013;PICHÉ et al, 2005 AHSAN; KHAN, 2013); à coagulação sanguínea (CALDER et al, 2013;TRACY et al, 1999) e proteínas de fase aguda (ENGSTRÖM et al, 2007;LEE et al, 2010;LEE et al, 2015;LUO et al, 2015;OLIVEIRA et al, 2015;ORTIZ et al, 2014;SITAR;AYDIN;CAKATAY, 2013;TESSEROMATIS et al, 2011;VAN CAMPENHOUT et al, 2003).…”
Section: Análise Quantitativa Dos Dados Da Proteômicaunclassified
“…Alpha-1-acid glycoprotein 1 (A1AG1) é uma proteína plasmática de fase aguda sintetizada pelo fígado e sua concentração sérica aumenta em resposta à lesão tecidual sistêmica, inflamação, infecção ou câncer (TESSEROMATIS et al, 2011). A1AG1 é considerada uma proteína de fase aguda positiva e um indicador de inflamação (LEE et al, 2015;LUO et al, 2015;OLIVEIRA et al, 2015;TESSEROMATIS et al, 2011).…”
Section: Alpha-1-acid Glycoproteinunclassified